The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine

R Moore, RS Purvis, DE Willis… - Clinical and …, 2022 - Wiley Online Library
Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19)
at both the individual and population levels. Vaccine hesitancy is identified as a significant …

[HTML][HTML] Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 …

J Serwanga, V Ankunda, J Sembera, L Kato… - Frontiers in …, 2023 - frontiersin.org
Introduction Understanding how spike (S)-, nucleoprotein (N)-, and RBD-directed antibody
responses evolved in mild and asymptomatic COVID-19 in Africa and their interactions with …

[HTML][HTML] COVID-19 in 16 West African countries: An assessment of the epidemiology and genetic diversity of SARS-CoV-2 after four epidemic waves

AJS Ndiaye, M Beye, A Sow, G Lo… - The American Journal …, 2023 - ncbi.nlm.nih.gov
West Africa faced the COVID-19 pandemic in early March 2020 and, as of March 31, 2022,
had more than 900,000 confirmed cases and more than 12,000 deaths. During this period …

[HTML][HTML] COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase

MJ Cummings, B Bakamutumaho, JJ Lutwama… - Nature …, 2024 - nature.com
Little is known about the pathobiology of SARS-CoV-2 infection in sub-Saharan Africa,
where severe COVID-19 fatality rates are among the highest in the world and the …

SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022

EM Bloch, D Kyeyune, JL White, H Ddungu… - …, 2023 - Wiley Online Library
Background The true burden of COVID‐19 in low‐and middle‐income countries remains
poorly characterized, especially in Africa. Even prior to the availability of SARS‐CoV‐2 …

A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform …

J Kitonsa, O Kamacooko, E Ruzagira… - Human vaccines & …, 2023 - Taylor & Francis
We report the screening and enrollment process for a phase I vaccine trial in Masaka,
Uganda that investigated the safety and immunogenicity of a self-amplifying SARS-CoV-2 …

Sub‐lineage B. 1.6 of hMPXV in a global context: Phylogeny and epidemiology

IS Molina, V Jimenez‐Vasquez… - Journal of Medical …, 2023 - Wiley Online Library
Abstract During the 2022 COVID‐19 pandemic, monkeypox emerged as a significant threat
to global health. The virus responsible for the disease, the human monkeypox virus …

[HTML][HTML] Uptake and effectiveness of a mobile application for real-time reporting and quality assurance of decentralized SARS-CoV-2 testing in Uganda

H Nansumba, P Nambuya, J Wafula, N Laiton… - Frontiers in Public …, 2023 - frontiersin.org
Background Effective management of the COVID-19 pandemic required rapid expansion of
diagnosis. The introduction of antigen tests presented an opportunity to decentralize testing …

[HTML][HTML] Assessing COVID-19 vaccine roll-out in Uganda: a case study of uptake and associated factors among health care workers and older people

UM Bahemuka, A Abaasa, R Asaba… - Open Research …, 2024 - openresearchafrica.org
Introduction We conducted a survey to investigate the uptake of COVID-19 vaccination
among healthcare workers (HCWs) and older persons (≥ 50 years) in Uganda, groups at …

OPEN ACCESS EDITED BY

S Kumar, M Kshirsagar, J Hu, R Ahmad… - Integrated waste …, 2023 - books.google.com
Background In the era of computers and technological gadgets, approximately 2.6 billion
people do not have clean cooking facilities, and if forecasts are correct this figure will remain …